Sharechat Logo

Serko first-half profit drops 16% as R&D, expansion costs mount

Tuesday 20th November 2018

Text too small?

Serko's first-half profit fell 16 percent as the travel booking software developer ramped up spending on research and development and a launch into new Northern Hemisphere markets. 

Net profit fell to $920,000 in the six months ended Sept. 30 from $1.2 million a year earlier. Serko achieved profitability in the March 2018 year and stayed in the black as first-half revenue climbed 23 percent to $11.8 million.

Operating costs were up 25 percent at $10.7 million as Serko hired more staff as its Zeno platform is deployed globally in a strategic partnership with ATPI Group. Headcount rose to 160 as at Oct. 31 from 106 at the end of March. 

Research and development spending jumped 58 percent to $3.8 million. That amounts to 34 percent of revenue, up from 27 percent a year earlier. Serko received a smaller government grant of $461,000 in the period. 

The software developer affirmed annual guidance for operating revenue to grow 20-to-30 percent, implying sales of $21.9 million to $23.8 million in the year ending March 31. Still, Serko expects earnings before interest, tax, depreciation and amortisation to be in line with last year's $2.2 million as it spends more on funding its global expansion. Ebitda rose 12 percent to $1.5 million in the six months ended Sept. 30. 

"We expect that the benefits of this investment will be apparent in the 2020 financial year," chair Simon Botherway said in a statement. "Serko is looking forward confidently to the next phase of our growth plan as we take Serko’s Zeno to the world." 

In August, the company raised $15 million in an over-subscribed placement to 12 institutional investors at $2.75 a share. That was a 3.2 percent discount at the time, but since then the stock has climbed as high as $3.47 in October and last traded at $3.29. 

Serko held cash and equivalents of $19 million as at Sept. 30, up from $4.6 million a year earlier. Its operating cash flow grew to $1.6 million from $327,000 a year earlier, while its capitalised R&D spending of $1.9 million and $226,000 purchase of plant, property and equipment took the investment outflow to $2.1 million. 

The company said it's using capital carefully to accelerate growth. It is also investigating potential acquisitions, it said, without providing details. 

(BusinessDesk)



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors